Transcript preview
Preview only
Nothing set on Xerox Research is the recommendation to buy or sell securities or tokens. This podcast is for informational purposes only, and any views expressed by anyone on the show are solely our opinions, not financial advice. Boccaccio, Ryan, and our guests may hold positions in the company's funds or projects discussed.
Hey. Welcome back to another livestream, Xerox Research, myself joined by Boccaccio. The music's still going. We love the feeding the ducks song, man. It's just so catchy. Joined by Boccaccio today as well as our very own Shonda Devens from the Walkers research team. How are we doing today, gentlemen?
Very good. Thank you for having me on, Danny.
Yeah. Thanks for having me on as well, man.
Always glad to have you on, Bok. Same with Shonda. I guess big big topic we wanna talk about today, obvious from the title. Bok, I'll maybe let you lead it in. But
Yeah. Maybe
over the timeline, all over the everyone's covering it, everyone's fighting over it. Take it away. Why do we why do we have Shonda on?
I guess, like, before we get into equity parts, I kinda wanna discuss something else. We're also really hyper liquid. I think if I try to discuss anything about hyper liquid with Sean that he would start freaking out. But they just announced cross portfolio margin. Did you see? Shonda. If
you Yeah. I just saw the update.
Keep exploring with a free account.
A free account preserves the short preview. Upgrade to Pro for the full transcript and episode chat.